InvestorsHub Logo
icon url

SkyLimit2022

12/28/23 1:35 PM

#659759 RE: learningcurve2020 #659757

LC,

Thanks for posting, but this sounds like another rumor to me. I ran it through the detector 😶 …



“This statement is composed of greater than 99% baseless innuendo for the following reasons:

1. **Speculative and Suggestive**: The statement is purely speculative, suggesting a scenario ("Powers could agree to provide L at cost") without any evidence or context to substantiate the claim.

2. **Implied Wrongdoing**: By saying "if you catch my drift," the statement implies wrongdoing or unethical behavior without directly stating it, which is characteristic of innuendo.

3. **Lack of Transparency Claim**: The assertion that "she's never shared a thing about the numbers with retail" is presented without evidence. It's important to note that companies have various regulatory and legal obligations regarding financial disclosures.

4. **Assumption of Malintent**: The statement assumes malintent on the part of Powers without providing factual support for such a claim.

The statement can also be considered potentially defamatory because it implies unethical or dishonest behavior on the part of Powers without providing any evidence. Defamation involves making false statements that harm someone's reputation. By suggesting improper conduct in a business setting without factual backing, the statement risks defaming Powers, especially if these insinuations are baseless and if Powers is a recognizable figure associated with a specific company or context. Such accusations, when unsubstantiated, can damage a person's professional reputation and credibility.

In summary, the statement relies on innuendo and speculation, lacking factual basis and unfairly implying wrongdoing without substantiation.”


https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html
Bullish
Bullish